Frequently asked questions
The COVID-19 pandemic has increased revenue in the protein sequencing market. The virus’s widespread nature compelled countries to conduct large-scale protein sequencing to gain insights into drug development.
In 2021, North America held the major global protein sequencing market share.
Protein sequencing has emerged as a popular high-throughput proteomic technique with numerous applications. The growing use of target-based drug design by pharmaceutical and biotechnology companies is expected to drive the global protein sequencing market throughout the projected period.
The Edman degradation segment had a major global market share in 2021.
The biopharmaceuticals segment had a major global market share in 2021.